Skip to main content


Fig. 5 | BMC Cancer

Fig. 5

From: Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients

Fig. 5

Rapid and persistent induction of antigen-specific CD8+ T cells during the vaccination. The PBMCs of Pt #1, 2 and 3 collected pre- or post-vaccination at different time points were analyzed using HLA-A*0201/NY-ESO-1 or HLA-A*0201/HIV-p24 multimer staining as negative control. The percentage of CD8+ multimer positive cells was calculated in the CD8 + CD19- gate and reported in figure. Vax 0 = pre-vaccination; Vax 3 = post 3rd vaccine administration; Vax 8 = post 8th vaccine administration

Back to article page